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CHAPTER TEN 
Division of Hematology 
ALLAN J. ERSLEV, M.D. 
"The blood is the life.)) 
-DEUTERONOMY 12:23 
I N THE early part of this century medicine began to change from an art to a science, from observation and palliation to testing and 
treatment. This change was associated with an 
increasing demand for doctors to be informed and 
experienced in the management of all illnesses, 
and it becanle more and more difficult to live up 
to the Oslcrian tradition of being a complete 
general physician. The field was too great; many 
physicians began to restrict their study to certain 
diseases and became recognized not for their 
breadth of knowledge but rather for their narrow 
competence in the malfunction of a single organ. 
At Jefferson, John Chalmers DaCosta, Jr., a cousin 
of John Chalmers DaCosta, the Gross Professor of 
Surgery, was the first American physician to write 
a textbook on hematology (Figure ro-l). This 
textbook, entitled Clinical Hematology) was first 
published in 1901 and predated Wintrobe's fanlous 
textbook of the same name by 4-1 years. A second 
edition appeared in 1905 and was used in the 
teaching of medical students during their rotation 
in the newly created Laboratory of Clinical 
Medicine. This laboratory, first installed in the 
Jefferson Medical College Annex building on 
Tenth Street, was then considered one of the first 
and most advanced developments in the use of a 
laboratory for medical teaching. It was directed in 
turn by Doctors Erwin D. F1Ulk, Henry Mohler, 
and IIarold Jones, but it was under Dr. Jones' 
leadership that it first became hematologically 
oriented. 
Early Hematology at Jefferson 
Dr. Harold W. Jones (1891-1959), after graduation 
from Jefferson in 1917, served as a Lieutenant in 
the Army Medical Corp at Fort Oglethorpe. From 
1919 to 1921 he was Chief Resident physician at 
Jefferson (figure 10-2). He practiced for a while as 
a general internist, but after being put in charge 
of the Laboratory of Clinical Medicine his interest 
turned to disorders of the blood. One of the main 
functions of the course in Laboratory Medicine 
then as now was to teach medical students how to 
examine and observe blood, but he realized that 
there was very little clinical or patll0physiologic 
follow-up. He suggested to Dr. Thomas McCrae, 
the Magee Professor of the Principles and Practice 
of Medicine, that Jefferson should establish what 
we now would designate as the Division of 
Hematology. Specifically, he suggested the 
development of three facilities: one for the 
accurate study of patients with blood disorders 
by specially trained technical and professional 
personnel; one consisting of laboratories for tlle 
long-term study of fundamental aspects of blood 
diseases; and one for a facility to provide 
transfusions of carefully matched blood. 
The present Division of Hematology was an 
outgrowth of these early ideas, but until 1939 
no organizational facility could be established 
because of lack of funds. Nevertheless, Dr. Jones 
proceeded with independent and unfunded studies 
of blood diseases and blood transfusions. He 
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published widely and wrote a numb~r of t~xtbook 
articles dealing with the problems of anemia, . 
hemorrhagic disorders, and the direct a!ld II1dlreet 
transfusion of blood. I Jones was one of the 
f<:lI.lIlders of the Jdkrson Society f()r Clinical 
Investig:ltion :It his :llm<1 mater. Nationally, he 
was known as <1n outstanding physICian :lnd 
hematologist, was elected to kllowship in the 
American College of Physicians, and was made a 
member of the Association of American PhYSICIans 
and the Interurban Club. 
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• Leandro M. Tocantins (1901-1963) 
In his work and hematologic interests Jones was 
supported by Dr. Leandto M. Tocantins (1901-
1963), a young Brazilian-born phYSICIan who 
graduated from Jefferson Medical College 111 the 
Class of 1926 after a classic premedICal education 
abroad and at Cornell University (Figure JO-3). 
He interned at Chestnut Hill Hospital and 
then practiced general medicine for three y~ars in 
Cleveland, Ohio. Tocantins returned to Jefferson 
and became a J. Ewing Mears Research Teaching 
Fellow until 1936, after which he received a faculty 
appointment. Dr. Tocantins early became involved 
in the study of hemostasis and blood coagulatIon, 
but his interests were, like those of Dr. Jones, 
directed at all aspects of hematology. He 
published widely on such diverse subjects as 
anti-platelet serum, urine antl-thromboplastll1, 
bone marrow infusions, lipid anticoagulants, and 
abnormal hemoglobins. As a special student of 
bleeding disorders, his name became linked to the 
effect of inhibitors of blood coagulatIon and 
especially the hypothesis that hemophilia is caused 
FIG. 10-2. Harold W Joncs, M.D. (1891-1919). 
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by such inhibitors. His work on blood platekts 
resulted in the classic monograph Mammalian 
Blood Platelets in Health and Disease) published in 
1938, which exerted a major influence on 
subsequent studies of this blood component? 
Tocantins also spearheaded the field of 
autoimmunity by infusing an anti-platelet serum 
and producing thrombocytopenia. This study 
led to attempts to treat both idiopathic 
thrombocytopenic purpura and acquired hemolytic 
anemia with macrophage blocking agents such as 
radioactive gold. 
These were years in which investigators 
provided for their own livelihood through busy 
medical practice and squeezed research into spare 
hours and free weekends. The new Magee 
Professor of Medicine, Dr. Hobart A. Reimann, 
was keenly aware of that and hoped for a day 
when investigators could be released from the 
burden of full-time practice and devote a major 
part of their time to scientific investigation within 
their special fields. Dr. Reimann was also a strong 
supporter of Dr. Jones' effort to develop a 
Division of Hematology, but funds were needed 
to fulfill these dreams. It was not until 1939, when 
Mr. and Mrs. Thomas D. Cardeza became 
interested in the project, that substantial baclung 
was obtained for the development of a 
research-oriented Division of Hematology. 
The Cardeza Foundation 
Mr. Thomas Drake Martinez Cardeza (1875-1952) 
was the last scion of the Drake fanlily, which came 
to the United States from Leeds, England in 1828 
(Figure 10-4). His ancestors Thomas Drake (1807-
1890) and his brother moved to Philadelphia from 
Ohio in 1837 and established a small woolen mill 
in Manayunk. They began to manufacture jeans 
under the trade name of "Kentucky Jeans." Their 
business prospered with the establishment of 
FIG. IO-'. Leandro M. Tocantins, M.D. (1901-196,). FIG. 10-4-. Thomas Drake Martinez Cardeza (1875-1952). 
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additional mills near the present South Street 
Bridge and at Twenty-first and Pine Streets. With 
the heavy demand for woolens by the Union 
Army, further expansion took place, and at the 
end of the Civil War Thomas Drake retired a 
wealthy man. He was highly respected in the 
business community and was able to augment his 
f()rtune with successful investments in real estate. 
He held a number of trusteeships and was an 
organizer and director of the old Fidelity Trust 
Company, a position he held until his death in 
[890. With his wik Matilda and seven children, 
Mr. Drake lived the style of the very rich. In his 
large estate in Germantown he had a small zoo, 
with free-roaming elks and bison, and kennels for 
Great Dane dogs. S:h.ily, six of his seven children 
died at a young age, many from scarlet fever, 
leaving Charlotte Drake ([854- [939) as the sole 
heiress to his fortune. 
In 1874, Charlotte married James Warburton 
Martinez Cardeza, the grandson of Count Juan 
Martmez Cardeza, a nobleman from La Coruna, 
Spain. However, 'lher her only son Thomas was 
born, she divorced and from then on devoted her 
lit<: to her son ,1lld to the sports and pleasures of 
the lc1sure cbss (figure 10-5). She and Thomas 
circumna\'ig,1ted the globe on her steam 
ocean-going y,1Chr, The Eleanor, with its crew of 39 
and guest rooms tor 16 (Figure 10-6). As an ardent 
and accomplished hunter she pursued big game in 
India and Africd. She ,lIld Thomas maintained a 
bunting lodge at Moose Head Lake in Maine, a 
shooting establishment in Montana, and a huntmg 
Schloss in Austria. She was also ,I patron of the 
opera and or the Academy of Music, and was 
a witty and beautiful lady of high society in 
Philadclphl:l. In 1912, she and Thomas were on the 
Tttamc together but both survived (Figure [0-7). 
All kinds of rumors were circulated afterwards 
about bow Tbomas had gotten into a lifeboat, 
rumors that undoubtedly made hiS survival 
ditlicult to enjoy. 
From all accounts, it appears that CharlOtte ran 
the family with a firm band. When Thomas 
married Mary Racine (1880-1943), another 
determined woman (Figure 10-8), he was caught 
between two strong-willed ladies separated by 
background and religion. Mary was born in 
France and was a Roman Catholic. They were 
married in secret, and the conversion of Thomas 
to Catholicism was difficult for Charlotte to 
accept. However, botb families lived in estates not 
far apart in Germantown and together they 
maintained the zoo and kennel established by 
Thomas Drake. 
After World War I, Mary developed a chronic 
incapacitating illness, the nature of which is 
unknowll, but it led her into a close personal and 
professional relationship with Dr. Harold Jones at 
Jefferson. He became a close friend of the family 
and treated Mrs. Cardeza both at home and in 
Jefferson hospital with a variety of medications, 
including direct infusions of small amounts of 
whole blood obtained from a donor at the 
bedside. He talked to them about his dream of 
establishing a transfusion and hematology research 
center at Jefferson. When Charlotte Drake Cardeza 
died in 1939, Thomas and Mary decided to 
support the development of such a center in her 
memory. 
FIG. 10-1. Mrs. Charlotte Drake Cardeza (1854--1939). 
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On December 14, 1939, at a memorable dinner 
at the University Club, attended by Mr. Cardeza 
and many department heads, Dr. Jones toasted the 
establishment of a Hematology Division in the 
Department of Medicine (Figure 10-9), to be 
nanled The Charlotte Drake Cardeza Fowldation 
for the Study of Diseases of the Blood and Allied 
Conditions. After two years of legal and academic 
discussions between Mr. J. Harry Wagner, legal 
counsel for the Cardezas, and Mr. Robert P. 
Hooper, President of the Board of Trustees of 
Jefferson, the Charlotte Drake Cardeza Foundation 
was formally incorporated on October 17, 1941, to 
be directed by Dr. Harold Jones, as the first 
Thomas Drake Martinez Cardeza Professor of 
Clinical Medicine and Hematology in the 
Department of Medicine (Figure 10-10). Jones was 
allotted a teaching service in the Department of 
Medicine, plus adult and pediatric hematology 
beds in the Hospital. Staff members for the 
Division of Hematology and a number of research 
and teaching Charlotte Drake Cardeza Fellows 
were recruited. The Division was to conduct and 
operate a Transfusion-Plasma Unit and a Biologic 
Photographic Unit, activities to be supported by 
an annual grant from the Cardezas of $50,000 for 
not less than ten years, $7,500 of which could be 
used tor the salary of the Director of the Division 
of Hematology. 
Although the Charlotte Drake Cardeza 
FIG. 10-0. Charlotte aod Thomas Drake Cardeza on board The Eleanor. 
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Foundation served as the Division of Hematology 
of the Department of Medicine, the Director 
reported to a Cardeza Foundation Advisory 
Committee of the faculty appointed by the Board 
of Trustees, rather than to the Chairman of the 
Department of Medicine. The Committee in turn 
reported to the Board of Trustees. Subsequent 
cJunges in the line of command provided tor two 
channels, one academic, via the Chairman of the 
Department of Medicine, and one fiscal, via a 
Cardeza Foundation Faculty Advisory Committee 
to a Joint Advisory Committee comprised of 
appropriate individuals representing the Board of 
Trustees, administration, faculty, and the Cardeza 
Trust. 
ML Cardcza was the first Chairman of the JOll1t 
Advisory Committee, and until 1947 he had almost 
0:::!.!_lH:'~' II" 
l>t ":;I:··••J...u:ll",:.I(~;.x~,,, ..~(....?ll, l",,',~ 
WHITE STAR LINE 
daily administrative contacts with Dr. Jones. At 
that point, he requested that Jefferson Medical 
College take over supervision of activities of the 
Foundation and changed the annual allotment 
of $50,000 to a corresponding amount derived 
from a Trust deposited at the Fidelity Bank. 
Mr. Horace Liversidge became Chairman, and 
Mr. Percival Foerderer and Mr. J. Harry Wagner 
were two of the more active committee members. 
With the additional support of a legacy of about 
$100,000 from the Kress brothers, considerable 
research was carried out in laboratories spread 
throughout the College. 
rn two small laboratories in the College 
Building and one in Room 247 in the Thompson 
Annex, Dr. Franklin A. Miller (Figure IO-II), who 
had been recruited as Assistant Director, and 
Dr. Leandro Tocantins, Co-Assistant Director, had 
for that period a great opportunity to pursue their 
research interest almost full-time. Dr. Miller's 
interest was in the pathogenesis of malignant 
lymphomas and leukemias. He succeeded in 
isolating from the urine of patients with these 
illnesses sever;}] substances that when injected into 
guinea pigs would alter cellular proliferation. 
FIG. 10-7. Cabin door hardware and receipts of the 
Cardeza passage on the Titanic. FIG. 10-8. Mary Racine (1880-1943).  
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Dr. Daniel Turner (Figure 10-12), an organic 
chemist, characterized these substances, and in 
many papers they hypothesized regarding their 
possible pathogenetic relationship to malignancy. 
Dr. Tocantins continued his work on platelets and 
the coagulation inhibitor found in some patients 
with hemophilia, and with Dr. Robert Carroll 
(Jefferson, 1952) and Dr. Ruth Holburn (Figure 
10-13) he established a Hemophilia Clinic. 
Dr. Jones was primarily involved in patient 
management centered around a clinic in the Curtis 
Building designated the Blood, Spleen, and 
Bone Marrow Clinic. With Dr. Lowell A. Erf, 
Jones also established a Blood Bank in a small 
building on Eleventh Street and became deeply 
involved in the processing and administration of 
plasma. 
In 1952, Mr. Cardeza died and left his estate for 
the support of The Charlotte Drake Cardeza 
Foundation. Mter some years of intense legal 
wrangling, his mansion in Germantown was 
PRoCEEDINCS OF THE DINNER 
HELD ON DECEMBER FOURTEENTIf. 1939 
TO CELEBRATE 
THE ESTASUSHMENT OF THE 
CHARLOnE ORAlE CABDEZA FOUNDATION 
roa THE STUDY OF 





~ ,.~ .~R.kM.. 
hG. 10-9. Dinner proceedings at the establishment of 
Charlotte Drake Cardeza Foundation. 
bequeathed to the Archdiocese of Philadelphia, 
and his fortune, about $3 million, was used to 
establish a trust for the Foundation with 
Mr. Wagner and the Fidelity Bank as co-trustees. 
This input of funds permitted the recruitment of 
more staff members. When Dr. Tocantins became 
the new vigorous Director in 1954-, he spearheaded 
nlrther expansion. Dr. Tocantins and Dr. Farid 1. 
Haurani (Figure 10-14-) began studies on bone 
marrow transplantation. Mter both exciting and 
painful experiences they learned that although 
autotransplantation was possible, still unknown 
immunologic barriers prevented successful 
heterotransplantation. 3 With the help of 
Dr. Louis A. Kazal (Figure 10-15), Dr. Daniel 
Turner, and Dr. Melvin J. Silver (Figure 10-16), 
Dr. Tocantins continued his quest for the 
identification of the elusive inhibitor that he 
believed characterized hemophilia.4- That quest was 
actually not finished until Dr. Sandor S. Shapiro 
(Figure 10-17), after the death of Dr. Tocantins, 
identified the inhibitor as a Factor VIn antibody 
that develops in about ten to 15 percent of treated 
patients with hemophilia.' 
In [959 Dr. Allan J. Erslev was recruited from 
the Thorndike Memorial Laboratory at Harvard as 
Associate Director. He pursued his work on 
erythropoietin, a renal hormone he had discovered 
earlier. This hormone controls the rate of red cell 
production and plays a major role in recovery 
from blood loss and in adaptation to high 
altitudes. D 
• The Sansom Street Center 
The trust income was, according to Mr. Wagner, 
restricted to support personnel and provide 
supplies and equipment and could not be used for 
renovation. Fortunately, a new chairman of the 
Joint Advisory Committee, Mr. J. I Ioward Pew, 
President of Sun Oil Company, saw the need for 
providing a separate building for the Foundation, 
and through his generosity a three-storied 
property on 1015 Sansom Street was purchased and 
completely renovated (figure 10-18). In [960, the 
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Foundation moved in and tor the first time 
became a coherent unit, permitting easy academic 
and personal interaction among its members. The 
move was followed by an expansion in personnel 
and activities, an expansion greatly enhanced by 
the new anilabiliry of federal research funds. In a 
few years, tCderal grant support actually matched 
and L:Xceeded trust income. The new Cardeza 
quarters housed the Blood Donor Center, a 
photographic unit, and laboratories and oftices 
for a professional staff that had increased to 
include 15 M.D.'s and Ph.D.'s, five to ten 
American and foreign clinical and Research 
Fellows, and a nonprofessional staff of about 60 
technicians, secretaries, and maintenance personnel. 
Academically, the Foundation was primarily the 
Division of Hematology in the Department of 
Medicine, bur it also served as the Division of 
Hematology in the Departments of Pediatrics, 
Physiology, and Pharmacology. It was responsible 
tor the teaching of hematology to students and 
house staft~ and clinically its members provided 
consultations and care for hematologic patients in 
the Jefferson Medical College Hospital. 
In 1963, after Dr. Tocantins' sudden death, 
Dr. Allan J. Erslcv (Figure 10-19), a native of 
Denmark (born in 1919), became Director. He 
continued the recruitment of new investigators 
and expansion of federal funding. Dr. Sandor 
Shapiro (Figure IO-17), the first senior recruit, was 
trained at Harvard and Massachusetts Institute of 
Technology; after arrival at Cardeza he established 
FIG. 10-10. Harold W JOIles, M.D. and his Cardeza StatT. 
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a Thrombosis and Hemorrhagic Disease Section 
and a state-supported Hemophilia Center. 
With Drs. Melvin Silver, Louis Kazal, Jose 
Martinez (Figure 10-20), and J. Bryan Smith 
(Figure 10-16), Shapiro spearheaded research in 
coagulation-factor kinetics, the immunologic 
basis for some coagulation disorders, and the 
biochemical processes involved in platelet 
aggregation and release action.7 - II Dr. Edward 
Burka, Dr. Elias Schwartz, Director of the 
Division of Pediatric Hematology, and Miss Jean 
Atwater (Figure IO-2T), Head of Cardeza 
Laboratories, studied normal and abnormal 
hemoglobins and identified the defects responsible 
for several hemoglobinopathies and 
thalassemias. 12 13 Their laboratories served as a• 
FIG. 1O-I2. Da.niel Turner, Ph.D. 
FIG. 10-11. Franklin R. Miller, M.D. FIG. 10-13. Ruth Holburn, Ph.D. 
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nationally recognlZ<.::d referral center for abnormal 
hemoglobins. Dr. Burka ,llso established a 
state-supported Sickle Cell Center ,lI1d became 
Blood Bank Director. These positions were 1,lter 
taken by Dr. S,1I1llr K. 13,llldS, with the ,Issistance 
of Dr. Stephen P. Hauptn1.1n t()r tissue typing ,lI1d 
Dr. Scott Murphy (Figure 10-22) t()r blood 
fractlon,1tion. Dr. 13,II].ls' Interest W,IS directed 
nuinly ,1t the red cell membr;me with Its extel'lLII 
antIgenic slte~ ,1I1d intern,ll structur,l] skelcton,'+ 
while Dr. Hauptm,1I1 studied the sal11(.' membr,1I1e 
structures on lymphocytes." Dr. Murph)' \ prImary 
interest was platelets, ,lI1d he established stor.lge 
condition,., t()r pl'ltekts that etfcctlvely incre,l.'>ed 
their shelf lite from hours to the present 
seven d,l)''', II, Dr. Susan TrJvis, who t()llowed 
Dr. Schwan7 ,\,,> Director of Pedi,ltric Hem,tto!ogy FIG, 10-tl Mr Olin Milkr (technician to Louis 1<"17;,11 t()r 
,0 \C,1I"). LOlli' A. K,1Z,11, Ph.D., and Sandor 
Sh,lf'll'O. M.D. 
FIG. fa-lb. Meh'lI1 J Silver, D.5e., and J Bryan 
FIG. 10-1+ F,lrId I Haur;1nl, M D Smith, Ph.D 
was primarily involved in unraveling red cell 
enzyme function. 17 Dr. Haurani's interest centered 
on iron and BI2 metabolism. He directed dle 
Jefferson branch of the National Cooperative 
Acute Leukemia Group B (ALGB). Dr. ErsJev 
continued his research in erythropoietin with 
Dr. Thomas Gabuzda, Dr. Ruth Silver, and 
Dr. Lewis KazaJ. Later, Dr. Jaime Caro joined his 
team and provided fi.lrther information about the 
renal biogenesis and bone marrow action of this 
hormone. Is They also established a research and 
referral center for erythropoietin bioassays and for 
the diagnosis of polycythemia vera, secondary 
polycythemia, and the anemia of chronic renal 
disease. 
Concomitantly with these research activities, all 
clinical members of the Cardeza Foundation were 
members of dle Cardeza Associates of Clinical 
Hematology and shared in consultations at the 
Thomas Jefferson University Hospital. With the 
competent support of some outstanding nurses, 
(Marian Ramp and Kay Houser are excellent 
examples), they provided in- and outpatient 
management of patients with hematologic 
FIG. 10-18. The Cardeza Foundation at lOIS Sansom Street. 
FIG. 10-]7. Sandor S. Shapiro, M.D Fw. IO-J9· Allan J. Erslev, M.D. (1919-). 
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disorders. Assisted by the more clinically oriented 
faculty members, Drs. John Hodges and Edward 
McGehee, they ,1lso taught hematology to 
Jefferson students and house staff and provided 
clinical and research instruction to Fellows 
supported by two National Institutes of Health 
Training Grants. 
Numerous reviews and textbook articles 
resulted. Dr. Erslev became coeditor of a major 
textbook, Hematology, 1<) and, with Dr. Gabuzda, 
coauthor of a small paperback Pathvphysiology of 
Blood. 20 Both books have gone through three 
editions. 
FIG. 10-21. Jean Atwater. 
In 1975, the Cardeza building had to make room 
for the new Thomas Jefferson University Hospital. 
The foundation moved into 1,600 square feet of a 
completely renovated laboratory and office space 
on the seventh, eighth, and ninth floors of the 
fIG. 10-20_ Jose M:lrtinez, M.D. hG. 10-22. Scott Murphy, M.D. 
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Curtis Building (Figure 10-23). The Cardeza Blood 
Donor Center and Tissue Typing Center as well as 
the Sickle Center moved into the first floor and 
the Cardeza Hcrnophilia Unit into the second 
floor of the old hospital, and the outpatient 
facilities were located eventually on the fourth 
floor of the New Hospital. The move into new 
laboratories symbolized the move in research 
£i'om the days of traditional morphologic and 
pathophysiologic studies to the current phase of 
molecular biology. Studies became characterized 
by monoclonal antibodies, restriction enzyme 
analysis, radioimmune assays, membrane receptor 
analysis, cell sorting, and gene cloning. Young 
investigators such as Drs. Perumal Thiagarajan, 
Carol lngerman-Wojenski, Patricia Catalano, 
Iftekhar Alam, and Jaime Caro adopted these new 
techOlques and turned research efforts at Cardeza 
in that direction. Although the funding never 
seemed to match expenditures, the annual Cardeza 
budget was maintained in precarious balance by 
the competent juggling of the administrative 
assistants, Bella Sigal and Helen Gilliam. In 1984-
1985, the budget reached about $3.5 million, with 
$2.3 miIJion provided from federal grants and 
contracts. 
In 1985 Dr. Erslev stepped down as Director 
of the Division but remained at Jefterson to 
continue his research on red cell diseases. He was 
immediately named Distinguished Professor of 
Medicine, the first in the Department of Medicine 
to be so honored. Previous awards included a 
Guggenheim Fellowship, presentation of his 
portrait by the Class of 1972, and the first 
FIG. ro'23. Hematology conference room and Leandro M. Tocantms LIbrary on the ninth floor of [he Cunis Building 
([975). 
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William B. Castle Lectureship at Boston 
University. He remained prominent in many of 
the important clinical and research societies related 
to his field both here and abroad. 
The Division may look back with pride to its 
contributions to the understanding and treatment 
of diseases of the blood and look forward under 
the new kJ.dership of Dr. Sandor Shapiro to the 
challenge of a future in hematologic molecular 
biology. 
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